Xia Y - Search Results

1

Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.

Wang QS, Li F, Liao ZQ, Li K, Yang XL, Lin YY, Zhao YL, Weng SY, Xia Y, Ye Y, Li SH, Wang CY, Lin Y. Wang QS, et al. Among authors: xia y. Cancer Med. 2019 Aug;8(9):4100-4109. doi: 10.1002/cam4.2313. Epub 2019 Jun 10. Cancer Med. 2019. PMID: 31183974 Free PMC article.

2

Regulation of the Expression of DAPK1 by SUMO Pathway.

Wang Q, Zhang X, Chen L, Weng S, Xia Y, Ye Y, Li K, Liao Z, Chen P, Alsamman K, Meng C, Stevens C, Hupp TR, Lin Y. Wang Q, et al. Among authors: xia y. Biomolecules. 2019 Apr 17;9(4):151. doi: 10.3390/biom9040151. Biomolecules. 2019. PMID: 30999631 Free PMC article.

3

Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.

Zhu Y, Wang Q, Xia Y, Xiong X, Weng S, Ni H, Ye Y, Chen L, Lin J, Chen Y, Niu H, Chen X, Lin Y. Zhu Y, et al. Among authors: xia y. BMC Cancer. 2020 Jul 10;20(1):644. doi: 10.1186/s12885-020-07125-4. BMC Cancer. 2020. PMID: 32650755 Free PMC article.

4

Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.

Wang Y, Qiao L, Yang J, Li X, Duan Y, Liu J, Chen S, Li H, Liu D, Fang T, Ma J, Li X, Ye F, Wan J, Wei J, Xu Q, Guo E, Jin P, Wu M, Zhang L, Xia Y, Wu Y, Shao J, Feng Y, Zhang Q, Yang Z, Chen G, Zhang Q, Li X, Wang S, Hu J, Wang X, Tan MP, Takabe K, Kong B, Yang Q, Ma D, Gao Q. Wang Y, et al. Among authors: xia y. Cancer Commun (Lond). 2021 Dec;41(12):1373-1386. doi: 10.1002/cac2.12233. Epub 2021 Nov 5. Cancer Commun (Lond). 2021. PMID: 34738326 Free PMC article.

5

The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.

Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Li ZY, Zhang RG, Zhu F, Wu G. Xia Y, et al. Int J Cancer. 2019 May 1;144(9):2227-2238. doi: 10.1002/ijc.31958. Epub 2018 Dec 6. Int J Cancer. 2019. PMID: 30374974 Free article.

6

Study on <em>CCDC69</em> interfering with the prognosis of patients with breast cancer through PPAR signal pathway.

Li J, Zhang P, Xia Y. Li J, et al. Among authors: xia y. Eur J Histochem. 2021 Feb 22;65(1):3207. doi: 10.4081/ejh.2021.3207. Eur J Histochem. 2021. PMID: 33634680 Free PMC article.

7

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma.

Xu J, Su Z, Cheng X, Hu S, Wang W, Zou T, Zhou X, Song Z, Xia Y, Gao Y, Zheng Q. Xu J, et al. Among authors: xia y. Cancer Cell Int. 2022 Mar 11;22(1):115. doi: 10.1186/s12935-022-02508-y. Cancer Cell Int. 2022. PMID: 35277179 Free PMC article.

8

[Effects of mitofusin-2 gene on proliferation and chemosensitivity of human breast carcinoma cell line MCF-7].

Xia Y, Wu YQ, Zhang L, Li XL, Yuan HL, He XJ, Tao DD, Gong JP, Qiu FZ. Xia Y, et al. Ai Zheng. 2007 Aug;26(8):815-9. Ai Zheng. 2007. PMID: 17697539 Free article. Chinese.

9

Clinical characteristics, pregnancy outcomes and ovarian function of pregnancy-associated breast cancer patients: a retrospective age-matched study.

Liao Q, Deng D, Xie Q, Gong X, Meng X, Xia Y, Ai J, Li K. Liao Q, et al. Among authors: xia y. BMC Cancer. 2022 Feb 7;22(1):152. doi: 10.1186/s12885-022-09260-6. BMC Cancer. 2022. PMID: 35130856 Free PMC article.

10

Ferroptosis: A Novel Anti-tumor Action for Cisplatin.

Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, Dai X, Li Z, Wu G. Guo J, et al. Among authors: xia y. Cancer Res Treat. 2018 Apr;50(2):445-460. doi: 10.4143/crt.2016.572. Epub 2017 May 10. Cancer Res Treat. 2018. PMID: 28494534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,160 results

Search Page